Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shanti Werther"'
Autor:
Raj Tummala, Susan Manzi, Gabriel Abreu, Catharina Lindholm, Ihor Hupka, Manish Shroff, Shanti Werther
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/724b4a9739ff46a3b2a4e33b1bf3fbb5
Autor:
Kenneth C. Kalunian, Richard Furie, Eric F. Morand, Ian N. Bruce, Susan Manzi, Yoshiya Tanaka, Kevin Winthrop, Ihor Hupka, Lijin (Jinny) Zhang, Shanti Werther, Gabriel Abreu, Micki Hultquist, Raj Tummala, Catharina Lindholm, Hussein Al‐Mossawi
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.)REFERENCES.
To explore long-term safety and tolerability of anifrolumab 300 mg compared with placebo in patients with systemic lupus erythematosus (SLE) who completed a Treatment of Uncontrolled Lupus via the Interferon Pathway (TULIP) trial and enrolled in the
Autor:
Shanti Werther, Omur Tabak, Byung Wan Lee, Salahedeen Abusnana, Susanna Lövdahl, Sultan Linjawi
Publikováno v:
Diabetes Therapy
Introduction This 32-week, open-label, randomized, parallel-group, multinational trial aimed to compare the efficacy and safety of stepwise insulin intensification of biphasic insulin aspart 30 (BIAsp 30) relative to stepwise intensification of a bas
Autor:
Jun Liu, Wenying Yang, Francis C.C. Chow, Shandong Ye, Canan Ersoy, Priti Kadu, Heng Miao, Guixia Wang, Shanti Werther, Arthur J Asirvatham
Publikováno v:
Diabetes research and clinical practice. 150
Aims To compare the efficacy and safety of biphasic insulin aspart 30 (BIAsp 30) administered three times daily (TID) vs. twice daily (BID), plus metformin, in patients with type 2 diabetes mellitus (T2DM) inadequately controlled on basal insulin ±